The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 16
- 16 new
- Median first-year cost
- $485,776
- $9,334,306 in all
- Institutions
- 14
- 15 contact PIs
Awards by fiscal year
0
0
0
0
0
0
0
16
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- OREGON HEALTH & SCIENCE UNIVERSITY2
- UNIVERSITY OF TEXAS HLTH SCIENCE CENTER2
- BAYLOR COLLEGE OF MEDICINE1
- CEDARS-SINAI MEDICAL CENTER1
- COLUMBIA UNIVERSITY HEALTH SCIENCES1
and 9 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 RPRB-8 (M2))3
- Special Emphasis Panel (ZCA1 SRB-E (M1))3
- Special Emphasis Panel (ZCA1 RPRB-6 (M2))1
- Special Emphasis Panel (ZCA1 RPRB-N (M2))1
- Special Emphasis Panel (ZCA1 RTRB-B (J1))1
and 7 other study sections
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2021 | Effects of Intermittent Energy Restriction on Intra-Abdominal Fat and the Gut Microbiome: A Randomized Trial1R01CA258179-01A1 | Boushey, Carol JLe Marchand, Loic | UNIVERSITY OF HAWAII AT MANOA, HI | First-year cost $1,104,814 | Study section ZCA1 |
| FY2021 | Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity1R01CA257807-01A1 | Tussing-Humphreys, LisaVarady, Krista Amy | UNIVERSITY OF ILLINOIS AT CHICAGO, IL | First-year cost $861,245 | Study section ZCA1 |
| FY2021 | Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators1R01CA258222-01 | Figueiredo, Jane C.Peterson, Courtney MarieSalvy, Sarah-Jeanne | CEDARS-SINAI MEDICAL CENTER, CA | First-year cost $779,477 | Study section ZCA1 |
| FY2021 | Impact of Time-Restricted Feeding in Reducing Cancer Risk Through Optimizing Mitochondria Function1R01CA258221-01A1 | Panda, Satchidananda | SALK INSTITUTE FOR BIOLOGICAL STUDIES, CA | First-year cost $762,137 | Study section ZCA1 |
| FY2021 | Patient-Generated Health Data to Predict Childhood Cancer Survivorship Outcomes1R01CA258193-01 | Huang, I-ChanYasui, Yutaka | ST. JUDE CHILDREN'S RESEARCH HOSPITAL, TN | First-year cost $742,807 | Study section ZCA1 |
| FY2021 | OPTIMISE: A Shared Care Approach for Improving Comprehensive Care of Cancer Patients with Comorbidities in A Safety-Net System1R01CA258040-01 | Badr, Hoda J.Mims, Martha P | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $657,655 | Study section ZCA1 |
| FY2021 | Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3)1R01CA258089-01 | Brown, JoelTsai, Kenneth Y | H. LEE MOFFITT CANCER CTR & RES INST, FL | First-year cost $640,021 | Study section ZCA1 |
| FY2021 | Addressing biological and therapeutic gaps in rare neuroendocrine cancer with a novel organoid-based model1R01CA264248-01 | Dahia, Patricia LealSoragni, Alice | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | First-year cost $525,382 | Study section ZCA1 |
| FY2021 | PAI-1-mediated early-onset endometrial cancer1R01CA257391-01 | Huang, Tim H.-M.Kirma, Nameer | UNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX | First-year cost $446,169 | Study section ZCA1 |
| FY2021 | PQ6: Therapeutic approaches for autonomic and neuroendocrine dysfunction in cancer cachexia1R01CA264133-01 | Marks, Daniel L. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $432,774 | Study section ZCA1 |
| FY2021 | Pathogenesis of Early Onset Colorectal Cancer: Microbiome Contributions and Mechanisms1R01CA264217-01 | Sears, Cynthia | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $421,420 | Study section ZCA1 |
| FY2021 | UNCOVER: underlying novel causes of onset of very early cancer research1R01CA257971-01A1 | Yang, Wan | COLUMBIA UNIVERSITY HEALTH SCIENCES, NY | First-year cost $411,409 | Study section ZCA1 |
| FY2021 | Drivers of histologic transformation in EGFR-mutant lung cancer1R01CA264078-01 | Rudin, Charles M.Yu, Helena | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $404,888 | Study section ZCA1 |
| FY2021 | PQ6: Lipocalin-2 as a therapeutic target for prevention of cancer cachexia1R01CA257452-01 | Marks, Daniel L. | OREGON HEALTH & SCIENCE UNIVERSITY, OR | First-year cost $393,676 | Study section ZCA1 |
| FY2021 | A Case-Control Study to Evaluate Broad-Spectrum Antibiotic use and High Birth Weight as Potential Risk Factors for Early-Onset Colorectal Cancer1R01CA258160-01A1 | Chao, Chun R. | KAISER FOUNDATION RESEARCH INSTITUTE, CA | First-year cost $379,857 | Study section ZCA1 |
| FY2021 | Targeting m6A RNA epigenetics in treatment-emergent neuroendocrine prostate cancer1R01CA258100-01 | Song, Min Sup | UNIVERSITY OF TX MD ANDERSON CAN CTR, TX | First-year cost $370,575 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-12-0.3.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.